BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31220641)

  • 1. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
    Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
    McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
    Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 4. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
    Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
    Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH1 and hereditary diffuse gastric cancer: a narrative review.
    Gregory SN; Davis JL
    Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
    Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
    Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).
    Hallowell N; Lawton J; Badger S; Richardson S; Hardwick RH; Caldas C; Fitzgerald RC
    J Genet Couns; 2017 Aug; 26(4):752-762. PubMed ID: 27837291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
    Kumar S; Long JM; Ginsberg GG; Katona BW
    World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
    Bryant MK; Sillcox R; Grady WM; Oelschlager BK
    Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study.
    Roberts G; Benusiglio PR; Bisseling T; Coit D; Davis JL; Grimes S; Guise TA; Hardwick R; Harris K; Mansfield PF; Rossaak J; Schreiber KC; Stanich PP; Strong VE; Kaurah P;
    Gastric Cancer; 2022 Nov; 25(6):1094-1104. PubMed ID: 35831514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'.
    Liu Y; Calzone K; Fasaye GA; Quillin J
    J Genet Couns; 2021 Aug; 30(4):1091-1104. PubMed ID: 33655597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
    Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
    J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision-making and regret in patients with germline
    Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
    J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
    Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
    JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
    Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
    Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and cancer risk in families with pathogenic
    Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
    J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations.
    Kumar S; Katona BW; Long JM; Domchek S; Rustgi AK; Roses R; Ginsberg GG
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):505-508.e1. PubMed ID: 31077828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.